Kwangdong Pharmaceutical광동제약

Kwangdong Pharmaceutical009290· Biotech & PharmaInitiation

Kwangdong Pharmaceutical: Thin Margins, Low Book Multiple and a Wide Model Range

Kwangdong Pharmaceutical's revenue has grown every year in the data, but operating margin stays near 2% and returns on equity are low. The shares trade at 0.5x book value and 15.2x earnings, and a model estimate sits above the current price with a very wide bear-to-bull range.

Oct 21, 20260 views